Patents by Inventor David W. Piotrowski

David W. Piotrowski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Quinuclidine-substituted hetero-bicyclic aromatic compounds for the treatment of disease
    Publication number: 20030073707
    Abstract: The invention provides compounds of Formula I: 1
    Type: Application
    Filed: June 6, 2002
    Publication date: April 17, 2003
    Inventors: Daniel Patrick Walker, Donn G. Wishka, Jeffrey W. Corbett, Mark R. Rauckhorst, David W. Piotrowski, Vincent E. Groppi
  • SUBSTITUTED-HETEROARYL-7-AZA[2.2.1] BYCYCLOHEPTANES FOR THE TREATMENT OF DESEASE
    Publication number: 20030069290
    Abstract: The invention provides compounds of Formula I: compounds of the Formula I: 1
    Type: Application
    Filed: August 14, 2002
    Publication date: April 10, 2003
    Inventors: Donn G. Wishka, Jason K. Myers, Bruce N. Rogers, Eric Jon Jacobsen, David W. Piotrowski, Jeffrey W. Corbett, Alice L. Bodnar, Vincent E. Groppi,
  • Substituted azabicyclic moieties for the treatment of disease
    Publication number: 20030055043
    Abstract: The invention provides compounds of Formula I: 1
    Type: Application
    Filed: April 17, 2002
    Publication date: March 20, 2003
    Inventors: Eric Jon Jacobsen, Daniel Patrick Walker, Jason K. Myers, David W. Piotrowski, Vincent E. Groppi
  • Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease
    Publication number: 20030045540
    Abstract: The invention provides compounds of Formula I: 1
    Type: Application
    Filed: June 6, 2002
    Publication date: March 6, 2003
    Inventors: Donn G. Wishka, Steven Charles Reitz, David W. Piotrowski, Vincent E. Groppi
  • Quinuclidine-substituted heteroaryl moieties for treatment of disease
    Patent number: 6500840
    Abstract: The invention provides compounds of Formula I: These compounds may be in the form of pharmaceutical salts or compositions, and racemic mixtures or pure enantiomers thereof. The compounds of Formula I are useful in pharmaceuticals in which &agr;7 is known to be involved.
    Type: Grant
    Filed: August 17, 2001
    Date of Patent: December 31, 2002
    Assignee: Pharmacia & Upjohn Company
    Inventors: Jason K. Myers, Bruce N. Rogers, Vincent E. Groppi, Jr., David W. Piotrowski, Alice L. Bodnar, Eric Jon Jacobsen, Jeffrey W. Corbett
  • Quinuclidine-substituted aryl compounds for treatment of disease
    Patent number: 6492386
    Abstract: The invention provides compounds of Formula I: These compounds may be in the form of pharmaceutical salts or compositions, and racemic mixtures or pure enantiomers thereof. The compounds of Formula I are useful in pharmaceuticals in which &agr;7 is known to be involved.
    Type: Grant
    Filed: August 17, 2001
    Date of Patent: December 10, 2002
    Assignee: Pharmacia & Upjohn Company
    Inventors: Jason K. Myers, Vincent E. Groppi, Jr., David W. Piotrowski
  • Quinuclidine-substituted heteroaryl moieties for treatment of disease
    Patent number: 6492385
    Abstract: The invention provides compounds of Formula I: These compounds may be in the form of pharmaceutical salts or compositions, and racemic mixtures or pure enantiomers thereof. The compounds of Formula I are useful in pharmaceuticals in which &agr;7 is known to be involved.
    Type: Grant
    Filed: August 17, 2001
    Date of Patent: December 10, 2002
    Assignee: Pharmacia & Upjohn Company
    Inventors: Jason K. Myers, Bruce N. Rogers, Vincent E. Groppi, Jr., David W. Piotrowski, Alice L. Bodnar, Eric Jon Jacobsen, Jeffrey W. Corbett
  • Quinuclidine-substituted aryl compounds for treatment of disease
    Patent number: 6486172
    Abstract: The invention provides compounds of Formula I: These compounds may be in the form of pharmaceutical salts or compositions, and racemic mixtures or pure enantiomers thereof. The compounds of Formula I are useful in pharmaceuticals in which &agr;7 is known to be involved.
    Type: Grant
    Filed: August 17, 2001
    Date of Patent: November 26, 2002
    Assignee: Pharmacia & Upjohn Company
    Inventors: Jason K. Myers, Vincent E. Groppi, Jr., David W. Piotrowski
  • Quinuclidine-substituted aryl compounds for treatment of disease
    Patent number: 6479510
    Abstract: The invention provides compounds of Formula I: These compounds may be in the form of pharmaceutical salts or compositions, and racemic mixtures or pure enantiomers thereof. The compounds of Formula I are useful in pharmaceuticals in which &agr;7 is known to be involved.
    Type: Grant
    Filed: August 17, 2001
    Date of Patent: November 12, 2002
    Assignee: Pharmacia & Upjohn Company
    Inventors: Jason K. Myers, Vincent E. Groppi, Jr., David W. Piotrowski
  • Quinuclidine-substituted heteroaryl moieties for treatment of disease
    Publication number: 20020091135
    Abstract: The invention provides compounds of Formula I: 1
    Type: Application
    Filed: August 17, 2001
    Publication date: July 11, 2002
    Inventors: Jason K. Myers, Bruce N. Rogers, Vincent E. Groppi,, David W. Piotrowski, Alice L. Bodnar, Eric Jon Jacobsen, Jeffrey W. Corbett
  • Quinuclidine-substituted aryl compounds for treatment of disease
    Publication number: 20020052389
    Abstract: The invention provides compounds of Formula I: 1
    Type: Application
    Filed: August 17, 2001
    Publication date: May 2, 2002
    Inventors: Jason K. Myers, Vincent E. Groppi, David W. Piotrowski
  • Quinuclidine-substituted aryl compounds for treatment of disease
    Publication number: 20020049225
    Abstract: The invention provides compounds of Formula I: 1
    Type: Application
    Filed: August 17, 2001
    Publication date: April 25, 2002
    Inventors: Jason K. Myers, Vincent E. Groppi, David W. Piotrowski
  • Quinuclidine-substituted heteroaryl moieties for treatment of disease
    Publication number: 20020042429
    Abstract: The invention provides compounds of Formula I: 1
    Type: Application
    Filed: August 17, 2001
    Publication date: April 11, 2002
    Inventors: Jason K. Myers, Bruce N. Rogers, Vincent E. Groppi, David W. Piotrowski, Alice L. Bodnar, Eric Jon Jacobsen, Jeffrey W. Corbett
  • Quinuclidine-substituted heteroaryl moieties for treatment of disease
    Publication number: 20020042428
    Abstract: The invention provides compounds of Formula I: 1
    Type: Application
    Filed: August 17, 2001
    Publication date: April 11, 2002
    Inventors: Jason K. Myers, Bruce N. Rogers, Vincent E. Groppi,, David W. Piotrowski, Alice L. Bodnar, Eric Jon Jacobsen, Jeffrey W. Corbett
  • Quinuclidine-substituted aryl compounds for treatment of disease
    Publication number: 20020040035
    Abstract: The invention provides compounds of Formula I: 1
    Type: Application
    Filed: August 17, 2001
    Publication date: April 4, 2002
    Inventors: Jason K. Myers, Vincent E. Groppi, David W. Piotrowski
  • Arthropodicidal anilides
    Patent number: 5602126
    Abstract: Substituted anilides of formula (I), wherein Q is one of (Q-1), (Q-2) and (Q-3), and R.sup.1 to R.sup.5, Y, Z and Z.sup.1 are as defined in the text, arthropodicidal compositions containing such compounds; and a method for controlling arthropods by use of such compounds.
    Type: Grant
    Filed: November 22, 1995
    Date of Patent: February 11, 1997
    Assignee: E. I. Du Pont de Nemours and Company
    Inventors: William E. Barnette, Charles R. Harrison, George P. Lahm, David W. Piotrowski, Keith D. Wing
  • Arthropodicidal anilides
    Patent number: 5500438
    Abstract: Substituted anilides of the formula ##STR1## wherein Q is one of ##STR2## and R.sup.1 to R.sup.5, Y, Z and Z.sup.1 are as defined in the text, arthropodicidal compositions containing such compounds; and a method for controlling arthropods by use of such compounds.
    Type: Grant
    Filed: November 22, 1993
    Date of Patent: March 19, 1996
    Assignee: E. I. Du Pont de Nemours and Company
    Inventors: William E. Barnette, Charles R. Harrison, George P. Lahm, David W. Piotrowski, Keith D. Wing